Ranek, Mark J.
Kokkonen-Simon, Kristen M.
Chen, Anna
Dunkerly-Eyring, Brittany L.
Vera, Miguel Pinilla
Oeing, Christian U.
Patel, Chirag H.
Nakamura, Taishi
Zhu, Guangshuo
Bedja, Djahida
Sasaki, Masayuki
Holewinski, Ronald J.
Van Eyk, Jennifer E.
Powell, Jonathan D.
Lee, Dong Ik
Kass, David A.
Article History
Received: 4 November 2018
Accepted: 13 December 2018
First Online: 30 January 2019
Competing interests
: D.A.K., J.D.P., M.J.R., K.M.K.-S. and C.H.P. are co-inventors on a patent application (PCT: 448070145WO1) that was filed in July 2018 (provisional filed in June 2017). The patent relates to the use of TSC2(S1365/S1364) modifications for immunological applications. D.A.K., J.D.P. and M.J.R. are co-founders and shareholders of Meta-T Cellular, a start-up company that aims to develop applications of this intellectual property for immune therapy.